Jennie Lin1, Yu Hu2, Sara Nunez2, Andrea S Foulkes2, Benjamin Cieply2, Chenyi Xue2, Mark Gerelus2, Wenjun Li2, Hanrui Zhang2, Daniel J Rader2, Kiran Musunuru2, Mingyao Li2, Muredach P Reilly1. 1. From the Renal, Electrolyte, and Hypertension Division, Department of Medicine, Perelman School of Medicine (J.L.), Department of Biostatistics and Epidemiology (Y.H., M.L.), Department of Genetics, Perelman School of Medicine (B.C., K.M., D.J.R.), and Cardiovascular Institute, Department of Medicine, Perelman School of Medicine (M.G., W.L., K.M.), University of Pennsylvania, Philadelphia; Irving Institute for Clinical and Translational Research (M.P.R.) and Division of Cardiology, Department of Medicine (C.X., H.Z., M.P.R.), Columbia University Medical Center, New York, NY; and Department of Mathematics and Statistics, Mount Holyoke College, South Hadley, MA (S.N., A.S.F.). linjenn@mail.med.upenn.edu mpr2144@cumc.columbia.edu. 2. From the Renal, Electrolyte, and Hypertension Division, Department of Medicine, Perelman School of Medicine (J.L.), Department of Biostatistics and Epidemiology (Y.H., M.L.), Department of Genetics, Perelman School of Medicine (B.C., K.M., D.J.R.), and Cardiovascular Institute, Department of Medicine, Perelman School of Medicine (M.G., W.L., K.M.), University of Pennsylvania, Philadelphia; Irving Institute for Clinical and Translational Research (M.P.R.) and Division of Cardiology, Department of Medicine (C.X., H.Z., M.P.R.), Columbia University Medical Center, New York, NY; and Department of Mathematics and Statistics, Mount Holyoke College, South Hadley, MA (S.N., A.S.F.).
Abstract
OBJECTIVE: Human macrophages can shift phenotype across the inflammatory M1 and reparative M2 spectrum in response to environmental challenges, but the mechanisms promoting inflammatory and cardiometabolic disease-associated M1 phenotypes remain incompletely understood. Alternative splicing (AS) is emerging as an important regulator of cellular function, yet its role in macrophage activation is largely unknown. We investigated the extent to which AS occurs in M1 activation within the cardiometabolic disease context and validated a functional genomic cell model for studying human macrophage-related AS events. APPROACH AND RESULTS: From deep RNA-sequencing of resting, M1, and M2 primary human monocyte-derived macrophages, we found 3860 differentially expressed genes in M1 activation and detected 233 M1-induced AS events; the majority of AS events were cell- and M1-specific with enrichment for pathways relevant to macrophage inflammation. Using genetic variant data for 10 cardiometabolic traits, we identified 28 trait-associated variants within the genomic loci of 21 alternatively spliced genes and 15 variants within 7 differentially expressed regulatory splicing factors in M1 activation. Knockdown of 1 such splicing factor, CELF1, in primary human macrophages led to increased inflammatory response to M1 stimulation, demonstrating CELF1's potential modulation of the M1 phenotype. Finally, we demonstrated that an induced pluripotent stem cell-derived macrophage system recapitulates M1-associated AS events and provides a high-fidelity macrophage AS model. CONCLUSIONS: AS plays a role in defining macrophage phenotype in a cell- and stimulus-specific fashion. Alternatively spliced genes and splicing factors with trait-associated variants may reveal novel pathways and targets in cardiometabolic diseases.
OBJECTIVE:Human macrophages can shift phenotype across the inflammatory M1 and reparative M2 spectrum in response to environmental challenges, but the mechanisms promoting inflammatory and cardiometabolic disease-associated M1 phenotypes remain incompletely understood. Alternative splicing (AS) is emerging as an important regulator of cellular function, yet its role in macrophage activation is largely unknown. We investigated the extent to which AS occurs in M1 activation within the cardiometabolic disease context and validated a functional genomic cell model for studying human macrophage-related AS events. APPROACH AND RESULTS: From deep RNA-sequencing of resting, M1, and M2 primary human monocyte-derived macrophages, we found 3860 differentially expressed genes in M1 activation and detected 233 M1-induced AS events; the majority of AS events were cell- and M1-specific with enrichment for pathways relevant to macrophage inflammation. Using genetic variant data for 10 cardiometabolic traits, we identified 28 trait-associated variants within the genomic loci of 21 alternatively spliced genes and 15 variants within 7 differentially expressed regulatory splicing factors in M1 activation. Knockdown of 1 such splicing factor, CELF1, in primary human macrophages led to increased inflammatory response to M1 stimulation, demonstrating CELF1's potential modulation of the M1 phenotype. Finally, we demonstrated that an induced pluripotent stem cell-derived macrophage system recapitulates M1-associated AS events and provides a high-fidelity macrophage AS model. CONCLUSIONS: AS plays a role in defining macrophage phenotype in a cell- and stimulus-specific fashion. Alternatively spliced genes and splicing factors with trait-associated variants may reveal novel pathways and targets in cardiometabolic diseases.
Authors: Jason M Johnson; John Castle; Philip Garrett-Engele; Zhengyan Kan; Patrick M Loerch; Christopher D Armour; Ralph Santos; Eric E Schadt; Roland Stoughton; Daniel D Shoemaker Journal: Science Date: 2003-12-19 Impact factor: 47.728
Authors: Ralph Burkhardt; Eimear E Kenny; Jennifer K Lowe; Andrew Birkeland; Rebecca Josowitz; Martha Noel; Jacqueline Salit; Julian B Maller; Itsik Pe'er; Mark J Daly; David Altshuler; Markus Stoffel; Jeffrey M Friedman; Jan L Breslow Journal: Arterioscler Thromb Vasc Biol Date: 2008-09-18 Impact factor: 8.311
Authors: Steve E Calvano; Wenzhong Xiao; Daniel R Richards; Ramon M Felciano; Henry V Baker; Raymond J Cho; Richard O Chen; Bernard H Brownstein; J Perren Cobb; S Kevin Tschoeke; Carol Miller-Graziano; Lyle L Moldawer; Michael N Mindrinos; Ronald W Davis; Ronald G Tompkins; Stephen F Lowry Journal: Nature Date: 2005-08-31 Impact factor: 49.962
Authors: Yi Xu; Chinnaswamy Jagannath; Xian-De Liu; Amir Sharafkhaneh; Katarzyna E Kolodziejska; N Tony Eissa Journal: Immunity Date: 2007-07-19 Impact factor: 31.745
Authors: Gregory A C Singer; Jiejun Wu; Pearlly Yan; Christoph Plass; Tim H M Huang; Ramana V Davuluri Journal: BMC Genomics Date: 2008-07-25 Impact factor: 3.969
Authors: Alexander N Orekhov; Tatiana Pushkarsky; Yumiko Oishi; Nikita G Nikiforov; Andrey V Zhelankin; Larisa Dubrovsky; Vsevolod J Makeev; Kathy Foxx; Xueting Jin; Howard S Kruth; Igor A Sobenin; Vasily N Sukhorukov; Emile R Zakiev; Anatol Kontush; Wilfried Le Goff; Michael Bukrinsky Journal: Exp Mol Pathol Date: 2018-08-16 Impact factor: 3.362
Authors: Emily B Lurier; Donald Dalton; Will Dampier; Pichai Raman; Sina Nassiri; Nicole M Ferraro; Ramakrishan Rajagopalan; Mahdi Sarmady; Kara L Spiller Journal: Immunobiology Date: 2017-02-20 Impact factor: 3.144
Authors: Bin Liu; Patrick Lindner; Adan Chari Jirmo; Ulrich Maus; Thomas Illig; David S DeLuca Journal: BMC Bioinformatics Date: 2020-01-28 Impact factor: 3.169
Authors: Elektra K Robinson; Pratibha Jagannatha; Sergio Covarrubias; Matthew Cattle; Valeriya Smaliy; Rojin Safavi; Barbara Shapleigh; Robin Abu-Shumays; Miten Jain; Suzanne M Cloonan; Mark Akeson; Angela N Brooks; Susan Carpenter Journal: Elife Date: 2021-05-28 Impact factor: 8.140